A retrospective study of postoperative targeted therapy in ALK-positive lung cancer

In this study, we aim to investigate the therapeutic effect and safety of ALK inhibitor in ALK-positive lung cancer patients. 59 patients with ALK-positive lung cancer from August 2013 to August 2022 were retrospectively recruited. The basic information, pathological type, clinical stage and treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Song, Yang, Chen, Zhuo, Su, Xiaona, Yang, Xin, Wei, Zhi, Chen, Junxia, Chen, Chuan, Li, Mengxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206081/
https://www.ncbi.nlm.nih.gov/pubmed/37221218
http://dx.doi.org/10.1038/s41598-023-34397-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206081/
https://www.ncbi.nlm.nih.gov/pubmed/37221218
http://dx.doi.org/10.1038/s41598-023-34397-0

Ejemplares similares